Found: Food, diet, nutrition and cancer
Oral Evidence Apr. 23 2024
Inquiry: Engineering biologyFound: to over 120 countries, and they are used for anything from infectious disease monitoring to human health
Oral Evidence Apr. 23 2024
Committee: Health and Social Care Committee (Department: Department of Health and Social Care)Found: We have to look after end of life care, the cancer model, that type of thing.
Written Evidence Apr. 23 2024
Inquiry: City Region and Growth DealsFound: other organisations to improve their performance by enhancing or introducing new products, processes, services
Asked by: Mochan, Carol (Scottish Labour - South Scotland)
Question
To ask the Scottish Government what recent preventative spend projects it has invested in, following the recommendations from the Accelerated National Innovation Adoption Pathway programme.
Answered by Gray, Neil - Cabinet Secretary for NHS Recovery, Health and Social Care
The Scottish Government is committed to unlocking the potential of scientific and technological innovation to transform lives, increase healthy life expectancy and reduce health inequalities across Scotland.
The Accelerated National Innovation Adoption (ANIA) pathway has been established to provide a national approach to the identification and adoption of research proven scientific and technological innovations. The ANIA pathway is led by the Centre for Sustainable Delivery, hosted by NHS Golden Jubilee. It is a collaborative venture that also draws on the expertise of NHS National Services Scotland, Healthcare Improvement Scotland, Public Health Scotland and NHS Education for Scotland.
The ANIA pathway is governed by an Innovation Design Authority (IDA). This brings together senior Scottish Government and NHS leadership to support improved partnership working, provide system leadership and take joint decisions on the progression of innovations through ANIA stage gates.
Following recommendations from the IDA, the Scottish Government has:
There are a range of further innovations currently being evaluated within the ANIA pathway. Scottish Ministers will consider investment in these programmes following any recommendation by the IDA.
Mentions:
1: Theresa Villiers (Con - Chipping Barnet) Will the Secretary of State support Breast Cancer Now’s campaign to improve the uptake of breast cancer - Speech Link
2: Andrew Stephenson (Con - Pendle) I am pleased that NHS England is reviewing mental health services for all staff, to ensure that all staff - Speech Link
3: Andrew Stephenson (Con - Pendle) NHS England is reviewing mental health services for all staff who need them, to ensure that they can - Speech Link
4: Helen Whately (Con - Faversham and Mid Kent) Friend rightly flags the excellent work going on to improve access to mental health services across the - Speech Link
Asked by: Alison McGovern (Labour - Wirral South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to improve the treatment of Cholangiocarcinoma cancers; and whether a proportion of the additional funding allocated to her Department in the Spring Budget 2024 will be used to treat Cholangiocarcinoma cancers.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Cancer is being diagnosed at an earlier stage, more often, with survival rates improving across almost all types of cancer, and the National Health Service has been seeing and treating record numbers of cancer patients over the last two years. Improving early diagnosis of cancer, including cholangiocarcinoma cancers, is a priority for the NHS. The NHS has an ambition to diagnose 75% of cancers at stage 1 or 2 by 2028, which will help tens of thousands of people live for longer.
Although funding for treatment isn’t allocated for specific cancers, the Government has provided significant additional funding to the NHS and adult social care in England. Measures introduced at the Spring Budget will protect levels of funding for the NHS in England in real terms in 2024/25, by providing an extra £2.5 billion for 2024/25, meaning a total budget of £164.9 billion.
While this additional spending is needed, the Government recognises that more money cannot always be the answer to improving outcomes for patients. Alongside the £2.5 billion of extra funding for day-to-day activities, the Government will invest £3.4 billion to reform the way the NHS works. This funding will significantly reduce the 13 million hours of time doctors spend on poor IT, freeing up significant capacity, and revolutionising treatment for a range of illnesses such as cancer and strokes. This will double the investment in technological and digital transformation in the NHS in England, and turn the NHS into one of the most digitally enabled, productive healthcare systems in the world.
On 14 August 2023, the Government published the Major Conditions Strategy’s Case for Change and Our Strategic Framework, which sets out our approach to making the choices over the next five years that will deliver the most value when facing the health challenges of today and of the decades ahead, including for cancer. It will look at the treatment and prevention of cancer, covering the patient pathway. The strategy will look at a wide range of interventions and enablers, to improve outcomes and experience for cancer patients.
Asked by: Andrew Selous (Conservative - South West Bedfordshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate she has made of the (a) cost to the NHS of lack of specialist bowel care for patients with neurogenic bowel disorders and (b) additional costs incurred by (i) diagnosis and treatment of pressure sores resulting from inadequate care and (ii) other secondary complications.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department has no plans at present to establish a national policy on neurogenic bowel disorder. To help ensure that patients with neurogenic bowel receive timely and appropriate care, NHS England has developed a range of guidance, including its Excellence in Continence Care guidance. NHS England has also published a service specification for spinal cord injury services, which makes specific reference to bowel care. It outlines that patients with spinal injury should be provided with advice and care by specialist nursing staff in specialist fields, including in the field of bladder and bowel management. In addition, National Institute for Health and Care Excellence guidelines on faecal incontinence set out the care that patients with neurogenic bowel should receive, including a neurological bowel management programme.
No estimate has been made of the cost to the National Health Service of a lack of specialist bowel care for patients with neurogenic bowel disorders. Nor has an estimate been made of the costs incurred by the diagnosis and treatment of pressure sores, resulting from inadequate care and other secondary complications.
Asked by: Andrew Selous (Conservative - South West Bedfordshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what her policy is on establishing a national policy for neurogenic bowel cancer; and what steps her Department is taking to ensure adequate care is available for people who need it.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department has no plans at present to establish a national policy on neurogenic bowel disorder. To help ensure that patients with neurogenic bowel receive timely and appropriate care, NHS England has developed a range of guidance, including its Excellence in Continence Care guidance. NHS England has also published a service specification for spinal cord injury services, which makes specific reference to bowel care. It outlines that patients with spinal injury should be provided with advice and care by specialist nursing staff in specialist fields, including in the field of bladder and bowel management. In addition, National Institute for Health and Care Excellence guidelines on faecal incontinence set out the care that patients with neurogenic bowel should receive, including a neurological bowel management programme.
No estimate has been made of the cost to the National Health Service of a lack of specialist bowel care for patients with neurogenic bowel disorders. Nor has an estimate been made of the costs incurred by the diagnosis and treatment of pressure sores, resulting from inadequate care and other secondary complications.
Asked by: Tulip Siddiq (Labour - Hampstead and Kilburn)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential implications for her policies of Pancreatic Cancer UK's Optimal Care Pathway recommendations.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
NHS England is delivering a range of interventions that are expected to increase early diagnosis, and improve outcomes for those with pancreatic cancer. This includes providing a route into pancreatic cancer surveillance for those at inherited high-risk, to identify lesions before they develop into cancer and diagnose cancers sooner, creating new pathways to support faster referral routes for people with non-specific symptoms that could be linked to a range of cancer types, and increasing general practice direct access to diagnostic tests. NHS England has also formed an expert group to consider a pathway for hepato-pancreato-biliary cancers, including pancreatic cancer.